Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00469612 · ClinicalTrials.gov registry record · NA
Evaluating NeuroVision's Neural Vision Correction (NVC) Myopia Treatment
A NA study, sponsored by Ohio State University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00469612: Clinical Trial NA study, sponsored by Ohio State University.
NCT00469612 is a NA study that was terminated before completion, run by Ohio State University. The registered enrollment target is 2 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00469612, a NA study, was terminated before completion, sponsored by Ohio State University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of the present study is to carry out a trial to evaluate the clinical efficacy of the NeuroVision Low Myopia Treatment. The specific questions to be answered are: 1. Is there an improvement in vision following the treatment without bringing about a change in the subject's prescription for glasses? 2. Can any treatment effect be seen at 6 months and 12 months after the termination of the treatment?
Interventions
- DEVICE NeuroVision's NVC treatment for Low Myopia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2007-06 |
| Est. Completion | 2009-12-01 |
| Phase | NA |
Why NCT00469612 stopped before completion
NCT00469612 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 2 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which NeuroVision's NVC treatment for Low Myopia is the first listed.
NCT00469612 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00469612 about?
NCT00469612 is a clinical study titled "Evaluating NeuroVision's Neural Vision Correction (NVC) Myopia Treatment". The purpose of the present study is to carry out a trial to evaluate the clinical efficacy of the NeuroVision Low Myopia Treatment. The specific questions to be answered are: 1. Is there an improvement in vision following the treatment without bringing about a change in the subject's prescription ...
What is the current status of trial NCT00469612?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2007-06. Estimated completion is 2009-12-01.
What interventions are being tested in trial NCT00469612?
The interventions under investigation include: NeuroVision's NVC treatment for Low Myopia (DEVICE).
Who is sponsoring clinical trial NCT00469612?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00469612's enrollment target sits among peer trials
2 1997th of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia